You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 20, 2024

CLINICAL TRIALS PROFILE FOR HDM201


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for HDM201

Trial ID Title Status Sponsor Phase Summary
NCT02143635 ↗ Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt Completed Novartis Pharmaceuticals Phase 1 To determine and evaluate a safe and tolerated dose of HDM201 in adult patients with selected advanced tumors characterized by wild-type TP53.
NCT02295722 ↗ GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma Unknown status Tom Baker Cancer Centre Phase 1/Phase 2 Objective of study: To evaluate the safety and efficacy of infusional gemcitabine prior to HDM (high-dose melphalan) as HDCT (High Dose Chemotherapy) followed by autologous stem cell transplantation in patients with relapsed/refractory lymphoma.
NCT02295722 ↗ GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma Unknown status AHS Cancer Control Alberta Phase 1/Phase 2 Objective of study: To evaluate the safety and efficacy of infusional gemcitabine prior to HDM (high-dose melphalan) as HDCT (High Dose Chemotherapy) followed by autologous stem cell transplantation in patients with relapsed/refractory lymphoma.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for HDM201

Condition Name

Condition Name for
Intervention Trials
Acute Myeloid Leukemia 2
Colorectal Cancer 2
Myelofibrosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Leukemia, Myeloid, Acute 4
Leukemia, Myeloid 4
Leukemia 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for HDM201

Trials by Country

Trials by Country for
Location Trials
United States 14
Spain 12
Germany 6
France 5
Australia 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for
Location Trials
New York 2
Massachusetts 2
Maryland 1
California 1
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for HDM201

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 2 1
Phase 1/Phase 2 6
Phase 1 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Recruiting 6
Not yet recruiting 4
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for HDM201

Sponsor Name

Sponsor Name for
Sponsor Trials
Novartis Pharmaceuticals 11
Centre Leon Berard 3
Novartis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 14
Other 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.